# Efficacy and Safety of An'Ningpai Expectorant in Non-CF Bronchiectasis

> **NCT04511897** · PHASE4 · UNKNOWN · sponsor: **Shanghai Pulmonary Hospital, Shanghai, China** · enrollment: 200 (estimated)

## Conditions studied

- Bronchiectasis Adult

## Interventions

- **DRUG:** An'ningpai

## Key facts

- **NCT ID:** NCT04511897
- **Lead sponsor:** Shanghai Pulmonary Hospital, Shanghai, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2022-12-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04511897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04511897, "Efficacy and Safety of An'Ningpai Expectorant in Non-CF Bronchiectasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04511897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*